A leading biopharmaceutical company focusing on the treatment of cancer and autoimmune diseases and ArriVent Biopharma.
Share: email Subscribe
Weekly Top Stories Tue, 18 Jul 2023
We have 30 articles this week. #Eli Lilly To Acquire # Versanis Bio. #Korro Bio and #Frequency Therapeutics Announce Merger Agreement .#Galmed Pharmaceuticals Announces Pricing of $7 Million Public Offering. #Acadia Pharmaceuticals Acquires Ex-North American Rights to Trofinetide and Global Rights to Neuren’s NNZ-2591 in Rett Syndrome and Fragile X Syndrome. #Revelation Pharma Completes Two Acquisitions
Editor's Choice
1. 
InnoCare and ArriVent Announce Clinical Development Collaboratio
2. 
Nona Biosciences Announces Business Update of Collaboration on Antibody Drug Conjugate (ADC) with DualityBio
3. 
Why PV Signal Teams Must Leverage RWD & Advanced Cognitive Computing
4. 
Verily & L’Oreal Launches Diverse Skin and Hair Health Registry.
5. 
Beacon Biosignals Acquires Dreem, Launches At-Home Sleep Monitoring Services for Clinical Trials
Top 10 M&A Transactions
6. 
Eli Lilly To Acquire Versanis Bio
7. 
Korro Bio and Frequency Therapeutics Announce Merger Agreement
8. 
Galmed Pharmaceuticals Announces Pricing of $7 Million Public Offering
9. 
Acadia Pharmaceuticals Acquires Ex-North American Rights to Trofinetide and Global Rights to Neuren’s NNZ-2591 in Rett Syndrome and Fragile X Syndrome.
10. 
Revelation Pharma Completes Two Acquisitions
11. 
Applied DNA Acquires RNA Polymerase Developer Spindle Biotech, Launches LineaIVT(TM) Platform to Substantially Improve mRNA Manufacturing and Broaden Market Reach.
12. 
ExoCoBio, A Leader in Exosome Technology, Completes the Acquisition of BENEV, a Global Medical Aesthetic Brand
13. 
AmplifyBio Completes Acquisition of Intellectual Property to Offer Non-Viral Gene Editing Services for Clients
14. 
Apollo Medical Holdings, Inc. Signs Definitive Agreement to Acquire Assets of Texas Independent Providers, Expanding Care Partners Business into Houston
15. 
Astellas Completes Acquisition of Iveric Bio
Top 4 Venture Funding
16. 
Caribou Biosciences Raises $125M Via Equity Just One Week After Pfizer Invested $25M
17. 
Causaly Secures $60M to Accelerate AI-Powered Biomedical Research
18. 
Israel Innovation Authority to Invest $31M to Establish R&D Infrastructure Center for Bio-Chips-Based Bio-Devices
19. 
Wavely Diagnostics Announces New Funding to Accelerate Commercial Launch, Scale Delivery of Only Digital Diagnostics Platform for Childhood Ear Infections
Top 4 Partnerships Announcements
20. 
Caribou Biosciences Commences $100M Public Offering of Shares
21. 
CVS Caremark Partners with GoodRx to Expand Low-Cost Drug Access.
22. 
Burjeel Holdings to Launch Rare Disease Research & Development Project ‘NADER’ in Partnership with US-Based BridgeBio Pharma
23. 
NeuroFlow, Novant Health Partner to Extend Mental Health Offerings.
Read More Corporate Development and M&A Activity
Get Featured: Send us your article or blog and we will feature it on our publication, reach over thousands of executives. Click Here.
Editor: Ed Francis

Ed has more than 25 years of management consulting experience and currently is the Global Managing Partner for Infosys Consulting Health and Life Sciences business guiding some of the industry's most prominent health and life sciences organizations through complex transformations.

If you need help with your complex transformation whether it be M&A, digital, or strategic cost reduction or need to bring more innovation into your business strategy Ed can be contacted at Edward.Francis@infosys.com and +1-847-910-6073

Or connect with him at

OTHER ADVISORIES

Health Plan Hospital IT
IT GovHealth
Retail POP Health
Ageing Life Sciences

Advertise with us

We Reach Half Million Decision Makers in:
Healthcare · IT · Retail · Industrial
Advertise with us and reach the right audience.
advertise@distilnfo.com

Contact Us

5760 Legacy Dr, B3-405,
Plano TX 75024
+1 469-270-3311

DistilINFO Publications

DistilINFO is media company that publishes Industry news, views and Interviews. We distil the information for you - saving time and keeping you up to date on your interest areas.

You are receiving this newsletter because you are subscribed to one or more DistilINFO Publications Newsletter/s. If you feel this email was sent by mistake or you want to opt out, you can unsubscribe.

View in browser | Advertise | Contact Us